Compare HCA Health Inc (HCA) vs D Wave Quantum Inc (QBTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs D Wave Quantum Inc — how do they compare? HCA Health Inc trades at $442.02 (market cap $96.35B), while D Wave Quantum Inc trades at $14.83 (market cap $5.54B). The key difference: HCA Health Inc is far larger — about 17.4× D Wave Quantum Inc's market cap, and HCA Health Inc pays a 0.7% dividend while D Wave Quantum Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and D Wave Quantum Inc for 32 Days on average.
| HCA | QBTS | |
|---|---|---|
Market Cap | $96.35B | $5.54B |
Volume | 1,079,453 | 16,671,452 |
Sector | Health | Technology |
52-Week High | $545.13 | $44.78 |
52-Week Low | $361.32 | $12.98 |
Typical Hold Time | 76 Days | 32 Days |
Enterprise Value | $146.88B | $5.04B |
Dividend Yield | 0.7% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare (HCA) trades at $439.17, up 1.61% on the day, with a bullish technical signal and strong fundamentals. The stock shows consistent revenue growth, reaching $75.6B in 2025, and has beaten EPS estimates for three consecutive quarters. Analyst consensus is bullish with a $461.12 price target, supported by solid cash flow from operations of $12.64B and a net income margin of 8.77%.
The outlook remains positive given earnings momentum and operational efficiency, but risks include ongoing legal investigations and high debt levels. Upside potential exists if the company maintains its earnings beat streak and manages payer-mix challenges effectively.
D-Wave Quantum Inc. (QBTS) trades at $15.22, down 3.61% on the day, reflecting a bearish technical trend. The company shows significant financial strain with a net income margin of -2001.59% and negative cash flow from operations. Despite this, all 13 covering analysts maintain a Buy rating with a consensus price target of $34.38, highlighting a stark divergence between current performance and long-term optimism.
The outlook is highly speculative. The potential reward is substantial if D-Wave achieves commercial success in quantum computing, but the risk is extreme due to persistent losses, high cash burn, and multiple ongoing securities fraud investigations, making it suitable only for risk-tolerant investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About D Wave Quantum Inc
D-Wave Quantum Inc. is a global leader in the development and delivery of quantum computing systems, software, and services. The company specializes in annealing quantum computers designed to solve complex optimization problems across industries such as logistics, materials science, and financial modeling. D-Wave offers its technology through the cloud, allowing customers to build and run real-world quantum applications today, making it a key player in the commercialization of quantum computing.
Read more on QBTS →
